# Bibliography: Evidence-Based Regulatory Frameworks for Drug Policy Reform

This comprehensive bibliography contains academic papers, policy analyses, government reports, and case studies related to regulatory models for drug policy reform.

## Policy Analysis and Framework Documents

### General Regulatory Approaches

Global Commission on Drug Policy. (2018). *Regulation: The responsible control of drugs*. Global Commission on Drug Policy.

Hughes, C. E., & Stevens, A. (2012). A resounding success or a disastrous failure: Re‐examining the interpretation of evidence on the Portuguese decriminalisation of illicit drugs. *Drug and Alcohol Review, 31*(1), 101-113.

International Drug Policy Consortium. (2021). *Principles for the responsible legal regulation of cannabis*. IDPC.

Kilmer, B. (2019). How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps. *American Journal of Drug and Alcohol Abuse, 45*(6), 664-672.

MacCoun, R., & Reuter, P. (2011). *Drug war heresies: Learning from other vices, times, and places*. Cambridge University Press.

Rolles, S. (2010). An alternative to the war on drugs. *BMJ, 341*, c3360.

Room, R., & Reuter, P. (2012). How well do international drug conventions protect public health? *The Lancet, 379*(9810), 84-91.

Transform Drug Policy Foundation. (2009). *After the war on drugs: Blueprint for regulation*. Transform Drug Policy Foundation.

Werb, D., Rowell, G., Guyatt, G., Kerr, T., Montaner, J., & Wood, E. (2011). Effect of drug law enforcement on drug market violence: A systematic review. *International Journal of Drug Policy, 22*(2), 87-94.

### Substance-Specific Regulatory Frameworks

Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017). Lower-risk cannabis use guidelines: A comprehensive update of evidence and recommendations. *American Journal of Public Health, 107*(8), e1-e12.

Foley, K., Levin, D., & Callaghan, P. (2021). The implications of cannabis policy liberalization. *New England Journal of Medicine, 384*(19), 1858-1861.

Rolles, S., & Murkin, G. (2016). *How to regulate cannabis: A practical guide*. Transform Drug Policy Foundation.

Rolles, S., & Slade, H. (2022). *How to regulate stimulants: A practical guide*. Transform Drug Policy Foundation.

Shanahan, M., Hughes, C., & Ritter, A. (2017). *Can regulatory frameworks help ensure medical cannabis is accessible, high-quality, and affordable?* International Journal of Drug Policy, 42, 111-114.

Strang, J., Groshkova, T., & Metrebian, N. (2012). *New heroin-assisted treatment: Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond*. European Monitoring Centre for Drugs and Drug Addiction.

Walsh, J., & Ramsey, G. (2016). *Uruguay's drug policy: Major innovations, major challenges*. Brookings Institution.

## Evidence from Implementation Case Studies

### Cannabis Models

Cerda, M., & Kilmer, B. (2017). Uruguay's middle-ground approach to cannabis legalization. *International Journal of Drug Policy, 42*, 118-120.

Fischer, B., Daldegan-Bueno, D., & Boden, J. M. (2020). Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, options and considerations. *Drug and Alcohol Review, 39*(6), 555-567.

Gettman, J., & Kennedy, M. (2014). *Let it grow—the open market solution to marijuana control*. Harm Reduction Journal, 11(1), 32.

Hall, W., & Lynskey, M. (2020). Assessing the public health impacts of legalizing recreational cannabis use: The US experience. *World Psychiatry, 19*(2), 179-186.

Kilmer, B., & Pacula, R. L. (2017). Understanding and learning from the diversification of cannabis supply laws. *Addiction, 112*(7), 1128-1135.

Pardal, M., Queirolo, R., Álvarez, E., & Repetto, L. (2019). Uruguayan cannabis social clubs: From activism to dispensaries? *International Journal of Drug Policy, 73*, 49-57.

Queirolo, R. (2020). Uruguay: The first country to legalize cannabis. In T. Decorte, S. Lenton, & C. Wilkins (Eds.), *Legalizing cannabis: Experiences, lessons and scenarios* (pp. 116-130). Routledge.

Room, R. (Ed.). (2013). *Cannabis policy: Moving beyond stalemate*. Oxford University Press.

### Psychedelics Regulation

Aday, J. S., Bloesch, E. K., & Davoli, C. C. (2020). 2019: A year of expansion in psychedelic research, industry, and deregulation. *Drug Science, Policy and Law, 6*, 1-6.

Carhart-Harris, R. L., & Goodwin, G. M. (2017). The therapeutic potential of psychedelic drugs: Past, present, and future. *Neuropsychopharmacology, 42*(11), 2105-2113.

Nichols, D. E., Johnson, M. W., & Nichols, C. D. (2017). Psychedelics as medicines: An emerging new paradigm. *Clinical Pharmacology & Therapeutics, 101*(2), 209-219.

Oregon Health Authority. (2022). *Oregon Psilocybin Services: Regulations and rules development*. Oregon Health Authority.

Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2020). Medicinal cannabis for psychiatric disorders: A clinically-focused systematic review. *BMC Psychiatry, 20*(1), 24.

Schlag, A. K., Aday, J., Salam, I., Neill, J. C., & Nutt, D. J. (2022). Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. *Journal of Psychopharmacology, 36*(3), 258-272.

### Harm Reduction and Higher-Risk Substances

Bardwell, G., Boyd, J., Arredondo, J., McNeil, R., & Kerr, T. (2019). Trusting the source: The potential role of drug dealers in reducing drug-related harms via drug checking. *Drug and Alcohol Dependence, 198*, 1-6.

Belackova, V., & Salmon, A. M. (2017). Overview of international literature: Supervised injecting facilities & drug consumption rooms. *Uniting Medically Supervised Injecting Centre*.

Farrell, M., & Hall, W. (2015). Heroin-assisted treatment: Has a controversial treatment come of age? *British Journal of Psychiatry, 207*(1), 3-4.

Oviedo-Joekes, E., Brissette, S., Marsh, D. C., Lauzon, P., Guh, D., Anis, A., & Schechter, M. T. (2009). Diacetylmorphine versus methadone for the treatment of opioid addiction. *New England Journal of Medicine, 361*(8), 777-786.

Strang, J., Groshkova, T., Uchtenhagen, A., van den Brink, W., Haasen, C., Schechter, M. T., ... & Metrebian, N. (2015). Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. *British Journal of Psychiatry, 207*(1), 5-14.

Strike, C., Watson, T. M., Kolla, G., Penn, R., & Bayoumi, A. M. (2015). Ambivalence about supervised injection facilities among community stakeholders. *Harm Reduction Journal, 12*(1), 26.

Tyndall, M. (2018). An emergency response to the opioid overdose crisis in Canada: A regulated drug supply. *Canadian Medical Association Journal, 190*(2), E35-E36.

## Public Health and Harm Reduction Integration

### Education and Prevention

Ennett, S. T., Tobler, N. S., Ringwalt, C. L., & Flewelling, R. L. (1994). How effective is drug abuse resistance education? A meta-analysis of Project DARE outcome evaluations. *American Journal of Public Health, 84*(9), 1394-1401.

Faggiano, F., Minozzi, S., Versino, E., & Buscemi, D. (2014). Universal school-based prevention for illicit drug use. *Cochrane Database of Systematic Reviews, 12*.

Midford, R. (2010). Drug prevention programmes for young people: Where have we been and where should we be going? *Addiction, 105*(10), 1688-1695.

Sumnall, H. R., & Brotherhood, A. (2012). *Social reintegration and employment: Evidence and interventions for drug users in treatment*. European Monitoring Centre for Drugs and Drug Addiction.

### Harm Reduction Services

Brunt, T. M. (2017). Drug checking as a harm reduction tool for recreational drug users: Opportunities and challenges. *European Monitoring Centre for Drugs and Drug Addiction*.

Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., ... & Beyrer, C. (2016). Public health and international drug policy. *The Lancet, 387*(10026), 1427-1480.

Harm Reduction International. (2020). *Global state of harm reduction 2020*. Harm Reduction International.

Kennedy, M. C., Karamouzian, M., & Kerr, T. (2017). Public health and public order outcomes associated with supervised drug consumption facilities: A systematic review. *Current HIV/AIDS Reports, 14*(5), 161-183.

Potier, C., Laprévote, V., Dubois-Arber, F., Cottencin, O., & Rolland, B. (2014). Supervised injection services: What has been demonstrated? A systematic literature review. *Drug and Alcohol Dependence, 145*, 48-68.

Strang, J., McDonald, R., Alqurshi, A., Royall, P., Taylor, D., & Forbes, B. (2016). Naloxone without the needle—systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal. *Drug and Alcohol Dependence, 163*, 16-23.

### Treatment Integration

Belenko, S., Hiller, M., & Hamilton, L. (2013). Treating substance use disorders in the criminal justice system. *Current Psychiatry Reports, 15*(11), 414.

Marel, C., Mills, K. L., Kingston, R., Gournay, K., Deady, M., Kay-Lambkin, F., ... & Teesson, M. (2016). *Guidelines on the management of co-occurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings*. Centre of Research Excellence in Mental Health and Substance Use.

Saloner, B., & Karthikeyan, S. (2015). Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004-2013. *JAMA, 314*(14), 1515-1517.

Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., ... & Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. *BMJ, 357*, j1550.

## Implementation and Market Design

### Institutional Frameworks

Caulkins, J. P., Kilmer, B., Kleiman, M. A., MacCoun, R. J., Midgette, G., Oglesby, P., ... & Reuter, P. H. (2015). *Considering marijuana legalization: Insights for Vermont and other jurisdictions*. RAND Corporation.

Kleiman, M. A. (2015). *Legal commercial cannabis sales in Colorado and Washington: What can we learn?* Brookings Institution.

Pardo, B. (2014). Cannabis policy reforms in the Americas: A comparative analysis of Colorado, Washington, and Uruguay. *International Journal of Drug Policy, 25*(4), 727-735.

Room, R. (2014). Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond. *Addiction, 109*(3), 345-351.

### Social Equity Implementation

Adinoff, B., & Reiman, A. (2019). Implementing social justice in the transition from illicit to legal cannabis. *The American Journal of Drug and Alcohol Abuse, 45*(6), 673-688.

Kilmer, B., Neel, E., & Everett, S. (2020). *Census of state and local drug enforcement agencies and cannabis regulatory agencies, 2019*. Bureau of Justice Statistics.

Lancione, S., Wade, K., Windle, S. B., Filion, K. B., Thombs, B. D., & Eisenberg, M. J. (2020). Non-medical cannabis in North America: An overview of regulatory approaches. *Public Health, 178*, 7-14.

Owusu-Bempah, A., & Luscombe, A. (2021). Race, cannabis and the Canadian war on drugs: An examination of cannabis arrest data by race in five cities. *International Journal of Drug Policy, 91*, 102937.

Valverde, M. (2017). Licenses and permits: A case study in public police. In M. Dubber & M. Valverde (Eds.), *The New Police Science* (pp. 163-185). Stanford University Press.

### Industry Structure

Caulkins, J. P., Kilmer, B., Kleiman, M. A., MacCoun, R. J., Midgette, G., Oglesby, P., ... & Reuter, P. H. (2015). *Options and issues regarding marijuana legalization*. RAND Corporation.

Decorte, T., Pardal, M., Queirolo, R., Boidi, M. F., Sánchez Avilés, C., & Franquero, Ó. P. (2017). Regulating cannabis social clubs: A comparative analysis of legal and self-regulatory practices in Spain, Belgium and Uruguay. *International Journal of Drug Policy, 43*, 44-56.

Haden, M., & Emerson, B. (2014). A vision for cannabis regulation: A public health approach based on lessons learned from the regulation of alcohol and tobacco. *Open Medicine, 8*(2), e73.

Pacula, R. L., Kilmer, B., Wagenaar, A. C., Chaloupka, F. J., & Caulkins, J. P. (2014). Developing public health regulations for marijuana: Lessons from alcohol and tobacco. *American Journal of Public Health, 104*(6), 1021-1028.

Rolles, S. (2020). The conflicted cannabis policy landscape in Canada. *Addiction, 115*(9), 1640-1641.

## Data Collection and Policy Adaptation

### Monitoring and Evaluation

Babor, T. F., Caulkins, J. P., Edwards, G., Fischer, B., Foxcroft, D. R., Humphreys, K., ... & Strang, J. (2018). *Drug policy and the public good*. Oxford University Press.

European Monitoring Centre for Drugs and Drug Addiction. (2019). *Monitoring and evaluating changes in cannabis policies: Insights from the Americas*. EMCDDA.

Fischer, B., Rehm, J., & Hall, W. (2009). Cannabis use in Canada: The need for a 'public health' approach. *Canadian Journal of Public Health, 100*(2), 101-103.

Kilmer, B., & Pacula, R. L. (2016). Understanding and learning from the diversification of cannabis supply laws. *Addiction, 112*(7), 1128-1135.

Pacula, R. L., & Smart, R. (2017). Medical marijuana and marijuana legalization. *Annual Review of Clinical Psychology, 13*, 397-419.

### Policy Adaptation Mechanisms

Hall, W., & Lynskey, M. (2016). Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA. *The Lancet Psychiatry, 3*(9), 900-906.

Hughes, C. E., Moxham-Hall, V., Ritter, A., Weatherburn, D., & MacCoun, R. (2017). The deterrent effects of Australian street-level drug law enforcement on illicit drug offending at outdoor music festivals. *International Journal of Drug Policy, 41*, 91-100.

Kilmer, B. (2017). Recreational cannabis—minimizing the health risks from legalization. *New England Journal of Medicine, 376*(8), 705-707.

MacCoun, R. J. (2011). What can we learn from the Dutch cannabis coffeeshop system? *Addiction, 106*(11), 1899-1910.

Rogeberg, O. (2018). Prohibition, regulation or laissez faire: The policy trade-offs of cannabis policy. *International Journal of Drug Policy, 56*, 153-161.

## Transition from Criminalization

### Criminal Justice Reform

Bewley-Taylor, D., Blickman, T., & Jelsma, M. (2014). *The rise and decline of cannabis prohibition*. Transnational Institute.

Csete, J. (2012). *A balancing act: Policymaking on illicit drugs in the Czech Republic*. Open Society Foundations.

Drug Policy Alliance. (2015). *The success of drug courts: Evidence-based approaches to drug crimes*.

Hughes, C. E., & Stevens, A. (2010). What can we learn from the Portuguese decriminalization of illicit drugs? *British Journal of Criminology, 50*(6), 999-1022.

Kleiman, M. A., Caulkins, J. P., & Hawken, A. (2011). *Drugs and drug policy: What everyone needs to know*. Oxford University Press.

Nadelmann, E. A. (2004). Criminologists and punitive drug prohibition: To serve or to challenge? *Criminology & Public Policy, 3*(3), 441-450.

Stevens, A. (2011). *Drugs, crime and public health: The political economy of drug policy*. Routledge.

### International Treaties

Bewley-Taylor, D. R. (2012). *International drug control: Consensus fractured*. Cambridge University Press.

Decorte, T., Lenton, S., & Wilkins, C. (Eds.). (2020). *Legalizing cannabis: Experiences, lessons and scenarios*. Routledge.

Jelsma, M., Boister, N., Bewley-Taylor, D., Fitzmaurice, M., & Walsh, J. (2018). *Balancing treaty stability and change: Inter se modification of the UN drug control conventions to facilitate cannabis regulation*. Transnational Institute, Global Drug Policy Observatory.

Room, R. (2012). Reform by subtraction: The path of denunciation of international drug treaties and reaccession with reservations. *International Journal of Drug Policy, 23*(5), 401-406.

## Implementation Timelines and Roadmaps

### Implementation Planning

Bennett, E. A., & Lemen, R. (2014). *Phased implementation: Effective way to plan and manage new policies*. Government Finance Review.

Caulkins, J. P., Kilmer, B., & Kleiman, M. A. (2016). *Marijuana legalization: What everyone needs to know*. Oxford University Press.

European Monitoring Centre for Drugs and Drug Addiction. (2021). *Cannabis: Controversies and challenges*. EMCDDA.

Hudak, J. (2020). *Marijuana: A short history*. Brookings Institution Press.

Kilmer, B., Caulkins, J. P., Bond, B. M., & Reuter, P. H. (2010). *Reducing drug trafficking revenues and violence in Mexico: Would legalizing marijuana in California help?* RAND Corporation.

### Lessons from Implementation

Caulkins, J. P., Hawken, A., Kilmer, B., & Kleiman, M. A. (2012). *Marijuana legalization: What everyone needs to know*. Oxford University Press.

Kilmer, B., & MacCoun, R. J. (2017). How medical marijuana smoothed the transition to marijuana legalization in the United States. *Annual Review of Law and Social Science, 13*, 181-202.

McGinty, E. E., & Barry, C. L. (2020). Stigma reduction to combat the addiction crisis—developing an evidence base. *New England Journal of Medicine, 382*(14), 1291-1292.

Room, R., Fischer, B., Hall, W., Lenton, S., & Reuter, P. (2010). *Cannabis policy: Moving beyond stalemate*. Oxford University Press.

## Additional Resources

### Government Reports and Policy Documents

Canadian Centre on Substance Use and Addiction. (2021). *Cannabis regulations: Lessons learned in Colorado and Washington State*. CCSA.

New Zealand Office of the Prime Minister's Chief Science Advisor. (2020). *Legalising cannabis: What does the evidence say?*

UK Health and Social Care Committee. (2019). *Drugs policy: First report of session 2019*. UK Parliament.

Washington State Liquor and Cannabis Board. (2021). *Annual report: Fiscal year 2021*. WSLCB.

### International Organizations

European Monitoring Centre for Drugs and Drug Addiction. (2022). *European drug report 2022: Trends and developments*. EMCDDA.

International Narcotics Control Board. (2020). *Report of the International Narcotics Control Board for 2020*. United Nations.

United Nations Office on Drugs and Crime. (2022). *World drug report 2022*. United Nations.

World Health Organization. (2016). *The health and social effects of nonmedical cannabis use*. WHO.

### Think Tank and NGO Reports

Brookings Institution. (2018). *Ending the U.S. government's war on medical marijuana research*. Brookings Institution.

Drug Policy Alliance. (2021). *From prohibition to progress: A status report on marijuana legalization*. Drug Policy Alliance.

Harm Reduction International. (2021). *The global state of harm reduction 2021*. HRI.

Washington Office on Latin America. (2020). *A guide to recreational cannabis regulations around the world*. WOLA.
